Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors

NCT01670175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumor
Childhood Solid Tumor

Interventions

DRUG: Sirolimus, Cyclophosphamide, Topotecan

Sponsor

University of California, San Francisco

Collaborators

[object Object]